Cargando…
Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)
PURPOSE: To test whether reducing radiation dose to uninvolved bladder while maintaining dose to the tumor would reduce side effects without impairing local control in the treatment of muscle-invasive bladder cancer. METHODS AND MATERIALS: In this phase III multicenter trial, 219 patients were rando...
Autores principales: | Huddart, Robert A., Hall, Emma, Hussain, Syed A., Jenkins, Peter, Rawlings, Christine, Tremlett, Jean, Crundwell, Malcolm, Adab, Fawzi A., Sheehan, Denise, Syndikus, Isabel, Hendron, Carey, Lewis, Rebecca, Waters, Rachel, James, Nicholas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier, Inc
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753507/ https://www.ncbi.nlm.nih.gov/pubmed/23958147 http://dx.doi.org/10.1016/j.ijrobp.2013.06.2044 |
Ejemplares similares
-
The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
por: Choudhury, Ananya, et al.
Publicado: (2017) -
Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial [Image: see text] ()
por: Huddart, Robert A., et al.
Publicado: (2020) -
Dynamic prediction methods in the BC2001 clinical trial
por: Porta, Nuria, et al.
Publicado: (2015) -
Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)
por: Paramasivan, Sangeetha, et al.
Publicado: (2011) -
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)
por: Nutting, Christopher M., et al.
Publicado: (2018)